RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PTCT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for PTC Therapeutics stock price on Monday moving between $29.11 and $32.61
(Updated on Apr 29, 2024)

Buy candidate since Apr 25, 2024 Gain 26.09% PDF

The PTC Therapeutics stock price gained 12.50% on the last trading day (Monday, 29th Apr 2024), rising from $28.57 to $32.14. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 12.03% from a day low at $29.11 to a day high of $32.61. The price has been going up and down for this period, and there has been a 25.16% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 120 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $52.09 million.

The stock lies in the upper part of a very wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $32.53 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 2.84% during the next 3 months and, with a 90% probability hold a price between $25.49 and $33.45 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PTCT Signals & Forecast

Mostly positive signals in the chart today. The PTC Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $26.87 and $28.00. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 30.17%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for PTC Therapeutics stock

PTC Therapeutics finds support from accumulated volume at $31.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.50 between high and low, or 12.03%. For the last week, the stock has had daily average volatility of 8.39%.

Our recommended stop-loss: $30.97 (-3.64%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (PTCT) For The Upcoming Trading Day Of Tuesday 30th

For the upcoming trading day on Tuesday, 30th we expect PTC Therapeutics to open at $31.29, and during the day (based on 14 day Average True Range), to move between $30.46 and $33.82, which gives a possible trading interval of +/-$1.68 (+/-5.24%) up or down from last closing price. If PTC Therapeutics takes out the full calculated possible swing range there will be an estimated 10.48% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $31.95, some $0.190 (0.59%) from the current price of $32.14, our system finds the risk reward attractive.

Is PTC Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for PTC Therapeutics stock to perform well in the short-term.

Current score: 4.324 Buy Candidate Unchanged

Predicted Opening Price for PTC Therapeutics of Tuesday, April 30, 2024

Fair opening price April 30, 2024 Current price
$31.29 ( 2.66%) $32.14

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PTCT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 34.79 8.24 %
R2 33.45 4.08 %
R1 32.62 1.51 %
Current price: 32.14
Support S1 29.95 -6.82 %
S2 29.12 -9.39 %
S3 27.78 -13.55 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 32.14
Support S1 31.95 -0.591%
S2 29.55 -8.06%
S3 25.32 -21.22%

FAQ

What is the symbol for PTC Therapeutics Stock and on which exchange is it traded?
The symbol for PTC Therapeutics is PTCT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell PTC Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for PTC Therapeutics stock to perform well in the short-term.

How to buy PTC Therapeutics Stock?
PTC Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PTC Therapeutics Stock.

What's the current price of PTC Therapeutics Stock?
As of the end of day on the Apr 29, 2024, the price of an PTC Therapeutics (PTCT) share was $32.14.

What is the 52-week high and low for PTC Therapeutics Stock?
The 52-week high for PTC Therapeutics Stock is $59.75 and the 52-week low is $17.53.

What is the market capitalization of PTC Therapeutics Stock?
As of the Apr 29, 2024, the market capitalization of PTC Therapeutics is 2.462B.

When is the next earnings date for PTC Therapeutics?
The upcoming earnings date for PTC Therapeutics is Aug 01, 2024.
Click to get the best stock tips daily for free!

About PTC Therapeutics

PTC Therapeutics PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offer... PTCT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT